
Take Solutions Ltd — Investor Relations & Filings
Take Solutions Ltd provides specialized domain-led technology and services, primarily focusing on the Life Sciences sector. Through its key brand, Navitas Life Sciences, the company delivers end-to-end solutions across clinical research, regulatory affairs, and pharmacovigilance. Its service offerings include clinical data management, medical writing, and trial monitoring, leveraging proprietary platforms to enhance operational efficiency. The organization supports pharmaceutical, biotechnology, and medical device companies in managing complex regulatory requirements and streamlining the drug development process. By combining deep functional expertise with digital transformation capabilities, Take Solutions facilitates data-driven decision-making and ensures compliance with global safety standards. Its portfolio encompasses strategic consulting and technology-enabled services designed to optimize clinical trial outcomes and accelerate time-to-market for new therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Notice of Postal Ballot dated May 13, 2026 | 2026-05-15 | English | |
| Shareholders meeting | 2026-05-15 | English | |
| Outcome of Board Meeting | 2026-05-13 | English | |
| Please find enclosed herewith the Outcome of the Board Meeting held on Wednesday, May 13, 2026, inter alia approving change in name of the Company, alteration and adoption of Memorandum .... | 2026-05-13 | English | |
| Press Release | 2026-04-17 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-13 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46351757 | Notice of Postal Ballot dated May 13, 2026 | 2026-05-15 | English | ||
| 46351614 | Shareholders meeting | 2026-05-15 | English | ||
| 45564189 | Outcome of Board Meeting | 2026-05-13 | English | ||
| 45552703 | Please find enclosed herewith the Outcome of the Board Meeting held on Wednesday, May 13, 2026, inter alia approving change in name of the Company, alteration and adoption of Memorandum .... | 2026-05-13 | English | ||
| 42209881 | Press Release | 2026-04-17 | English | ||
| 42189767 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-13 | English | ||
| 42213664 | Press Release | 2026-04-06 | English | ||
| 42163155 | Change in Auditors | 2026-03-26 | English | ||
| 42163370 | Outcome of Board Meeting | 2026-03-26 | English | ||
| 42178686 | Resignation | 2026-03-25 | English | ||
| 42179973 | Trading Window | 2026-03-25 | English | ||
| 42190231 | Press Release | 2026-03-25 | English | ||
| 42170276 | General Updates | 2026-03-11 | English | ||
| 42187987 | Shareholders meeting | 2026-03-07 | English | ||
| 42188107 | Shareholders meeting | 2026-03-07 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Vimta Labs Ltd.
Contract research and testing organization for life science…
|
VIMTALABS | IN | Professional, scientific and te… |
|
Vinext S.p.A.
Develops sustainable technology for the oenology and agri-f…
|
VNXT | IT | Professional, scientific and te… |
|
Virax Biolabs Group Ltd
Biotechnology company specializing in immune response detec…
|
VRAX | US | Professional, scientific and te… |
|
Viridian Therapeutics, Inc.\DE
Develops antibody-based therapies for serious and rare auto…
|
VRDN | US | Professional, scientific and te… |
|
VITRAFY LIFE SCIENCES LIMITED
Develops advanced cryopreservation and cold chain solutions…
|
VFY | AU | Professional, scientific and te… |
|
Viva Biotech Holdings
Integrated drug discovery, development, and manufacturing s…
|
1873 | KY | Professional, scientific and te… |
|
Viventia Biotech Inc.
Research and development of innovative, targeted oncology t…
|
— | CA | Professional, scientific and te… |
|
Vivo Bio tech Ltd.
Preclinical CRO providing drug discovery services and SPF l…
|
511509 | IN | Professional, scientific and te… |
|
VivoSim Labs, INC.
Develops 3D bioprinted human tissues for non-animal drug to…
|
VIVS | US | Professional, scientific and te… |
|
VOLITIONRX LTD
Epigenetics company developing blood tests for early diagno…
|
VNRX | US | Professional, scientific and te… |
Take Solutions Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60381/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60381 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60381 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60381 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60381}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Take Solutions Ltd (id: 60381)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.